Is ACRS Stock A Buy or Sell?
Is Aclaris Therapeutics, Inc. (NASDAQ:ACRS) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top...
Aclaris Therapeutics Inc. (ACRS)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 3,569,192 | $89,944 | +34% | 1.96% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 3,200,000 | $80,640 | +43% | 0.16% |
| 3. | Renaissance Technologies Jim Simons | 2,986,478 | $75,259 | -9% | 0.09% |
| 4. | Cormorant Asset Management Bihua Chen | 2,000,000 | $50,400 | 1.12% | |
| 5. | Foresite Capital Jim Tananbaum | 1,954,904 | $49,264 | +21% | 43.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.75 | 372,093 | Director | 1,911,573 | 2018-10-22 | Filing | |
| $14.00 | 7,100 | Director | 177,457 | 2018-10-04 | Filing | |
| $15.00 | 6,600 | Director | 170,357 | 2018-08-23 | Filing | |
| $15.97 | 6,250 | Director | 163,757 | 2018-08-15 | Filing | |
| $19.12 | 500 | Director | 500 | 2018-05-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.96 | 9,492 | Officer | 122,196 | 2021-06-03 | Filing | |
| $22.26 | 6,800 | Officer | 144,078 | 2021-06-02 | Filing | |
| $21.50 | 31,114 | Officer | 150,878 | 2021-06-02 | Filing | |
| $23.57 | 4,885 | Officer | 181,992 | 2021-06-01 | Filing | |
| $22.71 | 9,115 | Officer | 186,877 | 2021-06-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 6,110 | $153,972 | 1.8% | |
| 2. | 3,720,582 | $93,759 | 10.17% | |
| 3. | 3,399,034 | $85,656 | 10.26% | |
| 4. | 2,117,852 | $53,370 | 0% | |
| 5. | 1,500,974 | $37,825 | 0% |
News See All
Is ACRS A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious...
Hedge Funds Are Buying Aclaris Therapeutics, Inc. (ACRS)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings...
Is Aclaris Therapeutics, Inc. (ACRS) A Good Stock To Buy?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW)....
Did Hedge Funds Drop The Ball On Aclaris Therapeutics, Inc. (ACRS) ?
Is Aclaris Therapeutics, Inc. (NASDAQ:ACRS) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have...
Here’s What Hedge Funds Think About Aclaris Therapeutics, Inc. (ACRS)
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up...
Do Hedge Funds Love Aclaris Therapeutics, Inc. (ACRS)?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge...
Hedge Fund and Insider Trading News: Carl Icahn, Adage Capital Management, Pierre Andurand, Simpson Manufacturing Co, Inc. (SSD), Evans & Sutherland (ESCC), William Lyon Homes (WLH), and More
(Reuters) - SandRidge Energy Inc (SD.N) yielded to demands from top shareholder Carl Icahn on Monday and said it would evaluate any buyout offers, including one promised last week by the hedge fund manager...
Aclaris Therapeutics Inc (ACRS) Hedge Funds Are Snapping Up
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash...
Billionaire Hedge Funds
